// App-Quantinova.ai

: Development and Usability Testing of a Patient-based Digital Tool to Understand Early Signs of Changes in Multiple Sclerosis Symptoms and Progression: Your MS Questionnaire

Researchers

Presenter

  • Tjalf Ziemssen

Principal Investigators

  • Enrique Alvarez

  • Virender Bhan

  • Jason Burton

  • Olaf Hoffmann

  • Celia Oreja-Guevara

  • Ren Robles-Cedeo

  • Maria Trojano

  • Patrick Vermersch

  • Salvatore Napoli

  • Augusto Miravalle

  • Yan Xu

  • Jo Vandercappellen

  • Mudeer Khwaja

  • Mark Marchaterre

  • Bianca Stadler

  • Thomas Hach

  • Gavin Giovannoni

Medical Centers

  • Department of Rheumatology, University Clinic Carl-Gustav-Carus, Dresden, Germany

  • University of Colorado Denver School of Medicine, Aurora, CO

  • The University of British Columbia, Vancouver, BC, Canada

  • Centre for Neuromuscular and Neurological Disorders, Western Australian Neuroscience Research Institute, The University of Western Australia, Perth, Australia

  • Department of Neurology, Alexianer St. Josefs Hospital, Potsdam, Germany

  • Multiple Sclerosis Center at the University Hospital San Carlos, Madrid, Spain

  • Neuroimmunology and Multiple Sclerosis Unit, Girona, Spain

  • University of Bari, Bari, Italy

  • Univ. Lille, Inserm UMR U1172 LilNCog, CHU Lille, FHU Imminent, Lille, France

  • Partners, Multiple Sclerosis Center, and Center for Neurological Imaging, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

  • Department of Radiation Oncology, University of Colorado, Aurora, CO

  • Multiple Sclerosis Center, Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China

  • Novartis AG, Basel, Switzerland

  • Novartis Services, Inc.,East Hanover, NJ,Stati Uniti

  • Novartis Pharma GmbH, NÜRNBERG, Germany

  • Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Locations

  • Germany

  • United States

  • Canada

  • Australia

  • Spain

  • Italy

  • France

  • China

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved